Sunday, January 29, 2023

TOPICS

Home Tags EpiVax Inc.

Tag: EpiVax Inc.

EpiVax, Greenlight partner to produce mRNA cancer treatments

PROVIDENCE – Technology developed by EpiVax Therapeutics Inc. will power a new effort to produce individualized, mRNA vaccine-based cancer treatments in a partnership with...
A RECENT SURVEY conducted by the Grantmakers Council of Rhode Island and the United Way of Rhode Island show that the surveyed nonprofits are struggling financially, particularly with inflation. Many are also experiencing a staffing crisis. / PBN FILE PHOTO/KATE WHITNEY LUCEY

Survey: Local nonprofits struggling with financial, staffing woes

PROVIDENCE – A survey conducted by the United Way of Rhode Island and the Grantmakers Council of Rhode Island paints a bleak picture for...

EpiVax partners with Dutch company to produce universal coronavirus vaccine

PROVIDENCE – EpiVax Inc. is partnering with Intravacc to develop a universal vaccine for betacoronaviruses, including SARS-CoV-2. The project is funded by the Coalition for...

R.I. escalates efforts to contain monkeypox

Treating a cough or sore throat used to be a lot simpler. But since the COVID-19 outbreak more than two years ago, common symptoms...
Dr. Anne S. De Groot

Dr. Anne S. De Groot

SEEING BEYOND THE HORIZON has been a hallmark of EpiVax Inc. founder, CEO and Chief Science Officer Dr. Anne S. De Groot since she...
IN GOOD HANDS: Jennifer Beaugh, right, pharmacy supervisor at The Miriam Hospital, hands a dose of COVID-19 vaccine to Dr. Karen Tashima at a clinic at The Miriam. Tashima is overseeing a clinical trial of the COVID-19 vaccine that hasn’t yet received U.S. government approval.  / COURTESY LIFESPAN CORP.

R.I. plays role in making new COVID-19 vaccines

What seemed like an epic race for an effective COVID-19 vaccine has produced several options that have people rolling up their sleeves across Rhode...
THE U.S. FOOD and Drug Administration awarded a $1.1 million contract to EpiVax Inc. and collaborator CUBRIC Inc. for its research efforts.

FDA awards EpiVax $1.1 million research contract

PROVIDENCE – Biotechnology company EpiVax Inc. received $1.1 million in funding Wednesday from the U.S. Food and Drug Administration to further research efforts in...
PROVIDENCE BUSINESS NEWS honored 33 companies Wednesday for their revenue growth and innovation in the 2020 Fastest Growing & Innovative Companies Awards program.

Manufacturers, nonprofits, tech companies among honored in PBN’s 2020 Fastest Growing...

PROVIDENCE – Thirty-three companies were honored Wednesday by Providence Business News for their revenue growth and company innovation in the publication’s 2020 Fastest Growing...

EpiVax’s mission revolves around a culture of curiosity

PBN FASTEST GROWING COMPANIES 2020 $5M - $25M 5. EpiVax Inc. CEO (or equivalent): Dr. Anne De Groot, CEO and chief scientific officer 2019 Revenue: $6.8 million 2017...

PBN announces 2020 Fastest Growing & Innovative Companies

PROVIDENCE – Twenty local companies are among the highest earners on Providence Business News’ list of Fastest Growing Private Companies, and 13 companies are...
- Featured Event -

Latest News

CLOSE

70% OFF A ONE-YEAR SUBSCRIPTION

TODAY ONLY!